Skip to main content
  • Poster presentation
  • Open access
  • Published:

Corticosteroids for critically ill patients: an international survey of intensivists

Introduction

We surveyed intensivists to evaluate their stated use of systemic steroids in the ICU. The efficacy of steroids in septic shock and ARDS remains uncertain and clinicians' perceptions of competing indications and contraindications may jeopardize future randomized controlled trials (RCT). Knowledge of current practice will inform the design of future RCTs addressing the efficacy of systemic steroids in septic shock and ARDS.

Methods

We designed and conducted a self-administered survey of intensivists practicing in academic settings with expertise in ARDS clinical research. We generated questionnaire items in focus group sessions with content experts and refined them through a standardized process of clinical sensibility, pilot and intra-rater reliability testing. Respondents used a four-point scale to grade how frequently they would administer systemic steroids in a 14 different clinical situations and reported their opinions of 16 near absolute indications or contraindications for systemic steroids. Local research staff distributed the survey to all intensivists practicing in the 11 centres (Canada and USA) with most patients enrolled in the OSCILLATE trial.

Results

In total, 103 of 125 potential respondents returned completed surveys (response rate 82%). A majority of respondents 'almost always' prescribe systemic steroids in the setting of recent systemic steroid use and low blood pressure (93%), significant bronchospasm in a mechanically ventilated patient (93%) and vasopressor refractory septic shock (52%). A majority of respondents would 'almost never' prescribe steroids in severe community-acquired pneumonia (81%), ALI (76%) and ARDS (65%). One-half (50%) would 'almost never' prescribe steroids for severe ARDS (50%). The near absolute indications selected by a majority of respondents were 'known adrenal insufficiency' (99%) and 'suspicion of cryptogenic organizing pneumonia' (89%). The only near absolute contraindication selected by a majority of respondents was 'systemic fungal infection' (52%).

Conclusion

Certain clinical conditions may prompt intensivists to almost always prescribe systemic steroids and reduce equipoise for future placebo-controlled trials. Moreover, this survey shows that in selected academic centres a majority of intensivists do not prescribe corticosteroids for pneumonia, ALI and ARDS.

Author information

Authors and Affiliations

Authors

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Lamontagne, F., Adhikari, N., Cook, D. et al. Corticosteroids for critically ill patients: an international survey of intensivists. Crit Care 16 (Suppl 1), P101 (2012). https://doi.org/10.1186/cc10708

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc10708

Keywords